OSCR

Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway.

Overview

Authors: Zhilong Xu1,2, Jie Zhang2,3, Canrun Hu1,2, Yayan Luo1,2
  1. Institute of Neuropsychiatry, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
  2. Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China
  3. Department of Psychosomatic Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
Institutions: Guangzhou Medical University (China)
Journal: Frontiers in microbiology, volume 17, article 1765079
Dates: received 10 December 2025; accepted 9 March 2026; published online 7 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fmicb.2026.1765079 · PMID 42022121 · PMCID PMC13095750 · OpenAlex W7151525617
Open access: gold, a free copy (OpenAlex)
Categories: other condition (population), schizophrenia / psychosis (population), cellular / molecular (subfield)
Methods: Statistics, Preprocessing, Connectivity
Keywords: BDNF, gut microbiota, inulin, ketamine, SCFAs, schizophrenia
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 73 references in the paper

Abstract

Chronic ketamine exposure results in psychotic and cognitive symptoms that resemble those found in patients with schizophrenia. Emerging evidence suggests that patients with schizophrenia exhibit gut microbiota dysbiosis and decreased levels of short-chain fatty acids (SCFAs) and BDNF, which are related to the severity of psychotic and cognitive symptoms. Dietary inulin can regulate gut microbiota, SCFAs, and BDNF. However, the role of gut microbiota, SCFAs, and BDNF in chronic ketamine-induced schizophrenia-like behaviors is unclear. In this study, we found that chronic ketamine exposure for 28 days caused gut microbiota dysregulation, reduced the expression of SCFAs in serum, hippocampus, and feces, elevated gut permeability, downregulated the BDNF-TrkB-ERK1/2-CREB signaling pathway, caused neuronal damage, and decreased the expression of synaptic proteins Syn and PSD-95, which may lead to anxiety-like behaviors, prepulse inhibition (PPI) deficits, and spatial learning and memory deficits. In addition, inulin intervention reversed gut microbiota dysbiosis by decreasing the abundance of Colidextribacter, Oscillibacter, Alistipes, and Desulfovibrio, while increasing the abundance of Lachnospiraceae_NK4A136_group, Faecalibaculum, and Blautia. It also increased the expression of SCFAs, alleviated gut barrier damage, and upregulated the BDNF-TrkB-ERK1/2-CREB signaling pathway to reduce neuronal damage and enhance the expression of Syn and PSD-95, which may improve chronic ketamine-induced anxiety-like behaviors, PPI impairments, and spatial learning and memory deficits. Our findings provide additional evidence that inulin may be a promising candidate for treating chronic ketamine-associated anxiety-like behaviors and deficits in spatial learning and memory, as well as behavioral deficits in schizophrenia with dysbiosis.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The data presented in the study are deposited in the National Center for Biotechnology Information (NCBI) repository, accession number: PRJNA1437400, https://www.ncbi.nlm.nih.gov/sra/PRJNA1437400.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 4 authors, 6 keywords, 73 references.

Cite

This paper

Xu, Z., Zhang, J., Hu, C., & Luo, Y. (2026). Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway. Frontiers in microbiology, 17, 1765079. https://doi.org/10.3389/fmicb.2026.1765079

BibTeX

@article{xu2026inulin,
author = {Xu, Zhilong and Zhang, Jie and Hu, Canrun and Luo, Yayan},
title = {{Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway}},
journal = {Frontiers in microbiology},
year = {2026},
month = apr,
volume = {17},
pages = {1765079},
publisher = {Frontiers Media SA},
issn = {1664-302X},
doi = {10.3389/fmicb.2026.1765079},
url = {https://doi.org/10.3389/fmicb.2026.1765079},
pmid = {42022121},
pmcid = {PMC13095750}
}

RIS

TY - JOUR
AU - Xu, Zhilong
AU - Zhang, Jie
AU - Hu, Canrun
AU - Luo, Yayan
TI - Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway
T2 - Frontiers in microbiology
J2 - Front Microbiol
PY - 2026
DA - 2026/04/07
VL - 17
SP - 1765079
SN - 1664-302X
PB - Frontiers Media SA
DO - 10.3389/fmicb.2026.1765079
UR - https://doi.org/10.3389/fmicb.2026.1765079
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fmicb.2026.1765079",
"type": "article-journal",
"title": "Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway",
"container-title": "Frontiers in microbiology",
"author": [
{
"family": "Xu",
"given": "Zhilong"
},
{
"family": "Zhang",
"given": "Jie"
},
{
"family": "Hu",
"given": "Canrun"
},
{
"family": "Luo",
"given": "Yayan"
}
],
"container-title-short": "Front Microbiol",
"volume": "17",
"page": "1765079",
"DOI": "10.3389/fmicb.2026.1765079",
"PMID": "42022121",
"PMCID": "PMC13095750",
"ISSN": "1664-302X",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fmicb.2026.1765079",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
7
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41398-026-03965-z [code]
Disentangling individual heterogeneity reveals robust network and molecular signatures of major depressive disorder with suicidal ideation.
Journal: Translational psychiatry
In common: cellular / molecular, 3 references
[2] doi:10.34133/research.1115 [code]
Heterogeneity-Aware, Multiscale Annotation of Shared and Specific Neurobiological Signatures among Major Neurodevelopmental Disorders.
Journal: Research (Washington, D.C.)
In common: other condition, 2 references
[3] doi:10.3390/ijms231911245
The Microbiota-Gut-Brain Axis in Psychiatric Disorders.
Journal: International journal of molecular sciences
In common: schizophrenia / psychosis, 2 references
[4] doi:10.3389/fmicb.2026.1811435
Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology.
Journal: Frontiers in microbiology
In common: 2 references
[5] doi:10.1038/s41398-025-03615-w
The association between gut microbiota and functional connectivity in cognitive impairment of first-episode major depressive disorder.
Journal: Translational psychiatry
In common: 2 references
[6] doi:10.1136/gpsych-2023-101374
Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications.
Journal: General psychiatry
In common: 2 references
[7] doi:10.3390/ijms24076617
Gut Microbiota Metabolites Differentially Release Gliotransmitters from the Cultured Human Astrocytes: A Preliminary Report.
Journal: International journal of molecular sciences
In common: cellular / molecular, 2 references
[8] doi:10.1186/s13041-025-01255-1
Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.
Journal: Molecular brain
In common: schizophrenia / psychosis, other condition, cellular / molecular, 1 reference
[9] doi:10.3389/fnana.2025.1589287
Selective vulnerability of stellate cells to gut dysbiosis: neuroanatomical changes in the medial entorhinal cortex.
Journal: Frontiers in neuroanatomy
In common: 2 references
[10] doi:10.3389/fmicb.2023.1094071 [code]
Influence of mental health medication on microbiota in the elderly population in the Valencian region.
Journal: Frontiers in microbiology
In common: cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.